Rare Disease Account Manager — Field Sales Leader

Amgen Inc.; Jacksonville (FL); Hybrid; USD 145.000 - 215.000; Vollzeit

Benefits dieser Stelle

Retirement and Savings Plan

Medical, dental and vision coverage

Life and disability insurance

Flexible spending accounts

Sales incentive programs

Zusammenfassung

Amgen Inc. is seeking a Specialty Account Manager for Rare Disease to lead account management and drive product demand across designated geographies.

You will educate healthcare professionals on patient care options, coordinate with field teams, and address access and reimbursement issues in collaboration with market access and patient services. The role requires building strong customer relationships, achieving sales goals, and maintaining compliant communications per PhRMA and company

Qualifikationen

• Bachelor’s Degree and 3 years of sales experience in pharma/biotech/medical devices or hospital sales.
• Associate degree and 6 years of sales experience in pharma/biotech/medical devices or hospital sales.
• High school diploma/GED and 8 years of sales experience in pharma/biotech/medical devices or hospital sales.

Aufgaben

• Represent UPLIZNA to physicians and health care professionals.
• Perform territory account management and drive product demand.
• Coordinate with field teams to support account needs and reimbursement.

Kenntnisse

Interpersonal skills

Written & verbal communication

Professional demeanor

Team collaboration

Ausbildung

Bachelor’s degree

Associate degree

Master’s degree

Doctorate

Tools

Microsoft Office

Jobbeschreibung

Amgen Inc. is seeking a Specialty Account Manager for Rare Disease to lead account management and drive product demand across designated geographies.

You will educate healthcare professionals on patient care options, coordinate with field teams, and address access and reimbursement issues in collaboration with market access and patient services. The role requires building strong customer relationships, achieving sales goals, and maintaining compliant communications per PhRMA and company